People in the United States who bought Solgar Formula VM-75 multivitamins. The proposed class covers all U.S. buyers of that product.
Plaintiffs sued Nestlé Health Science and Nestlé S.A. in New Jersey federal court on October 21, 2026. They say VM-75 contains high doses of vitamin B6 without a warning about nerve damage. The case is at an early stage.
Nothing yet. There is no settlement and no claim form. Any payout would depend on what a court or a settlement decides later.
You do not need to file anything to be part of a proposed class. If you were harmed, a lawyer can explain your own claim and your state's deadline.
Many product liability lawyers take cases on contingency, so you pay nothing up front and the fee comes out of any recovery.
A new proposed class action says Solgar Formula VM-75 multivitamins contain far more vitamin B6 than most people need and do not warn buyers that long term high doses can damage nerves. Nestlé, which owns Solgar, has been sued over the claim. This page explains what the lawsuit says, how much B6 is too much, and what you can do now.
The case was reported by ClassAction.org. These are allegations, not proven facts, and this page is general information and not legal or medical advice.
Important Solgar vitamin B6 update
As of November 2, 2026, there is no settlement and no claim form in the Solgar case. Any website offering to sign you up for a payout is a warning sign. If you take VM-75, talk to your doctor before you change your supplements, especially if you notice numbness or tingling. See our guide to class action settlements with no proof of purchase for how real claims work.
The case is Higgins et al. v. Nestlé Health Science US Holdings, Inc. and Nestlé S.A., No. 2:26-cv-13703, filed in federal court in New Jersey on October 21, 2026. The complaint says Nestlé Health Science bought Solgar in 2021 and knew, or should have known, about the risks of high dose B6. The plaintiffs ask to represent everyone in the United States and its territories who bought Solgar Formula VM-75.
The U.S. National Institutes of Health says most adults need 1.3 to 1.7 mg of B6 a day and sets an upper limit of 100 mg a day for adults. Its fact sheet says severe nerve damage has been linked to long term doses of 1 to 6 grams a day, and that some reports describe problems below 500 mg. Studies of people taking about 200 mg a day for up to five years found no such effect. Europe sets lower limits. You can read the facts at the NIH Office of Dietary Supplements.
| Source | B6 amount per day | What it means |
|---|---|---|
| NIH recommended intake | 1.3 to 1.7 mg | What most adults need |
| U.S. upper limit (NIH) | 100 mg | Highest daily dose unlikely to cause harm |
| European Food Safety Authority (2023) | 12 mg | A much lower European limit |
| Solgar VM-75 (per the complaint) | 75 mg | Under the U.S. limit, far over the European one |
That gap is the heart of the case. The plaintiffs argue regulators in the UK, the EU, the Netherlands and Norway set limits of 10 to 25 mg, and that Australia has required warning labels on high dose B6 since March 2022.
Anyone who bought VM-75 could fall into the proposed class. People who took it every day for years, or who also take other B6 products, have the most to check.
The complaint relies on consumer protection and product laws, including the California Unfair Competition Law, the California Consumers Legal Remedies Act, the Song-Beverly Consumer Warranty Act, the New Jersey Consumer Fraud Act and the New Jersey Products Liability Act. In plain terms, the plaintiffs say the product was marketed in a misleading way and sold without a needed warning.
Check your bottle today.
Read the label to see how much B6 is in each serving and keep the bottle and receipt in case you need them later.
You do not need to join anything today, but a few steps will protect your health and your options.
Our guide on how to sue a company explains the basic steps before you talk to a lawyer.
The case is at the start. Nestlé will likely respond to the complaint, and the court will later decide whether the case can proceed as a class action. Cases like this often take years, and I found no ruling, hearing date or settlement so far.
There is no class deadline yet because there is no settlement. For your own injury claim, the time limit depends on your state and is often a few years, so do not wait. A lawyer can tell you which deadline applies to you. The key dates so far are:
Case: Higgins et al. v. Nestlé Health Science US Holdings, Inc.
Case number: 2:26-cv-13703
Court: U.S. federal court, New Jersey
Health facts: NIH vitamin B6 fact sheet
Yes. A proposed class action was filed on October 21, 2026 in New Jersey federal court against Nestlé Health Science US Holdings and Nestlé S.A. The claims are allegations and have not been proven.
The reported complaint names Solgar Formula VM-75 multivitamins. Check the label of any other Solgar product you take for its B6 amount.
According to the complaint, VM-75 contains 75 mg of vitamin B6 per daily dose. That is under the 100 mg U.S. upper limit but well above limits set in Europe.
The NIH says long term high doses of B6 can cause nerve damage called sensory neuropathy, with symptoms that can include numbness and balance problems. Symptoms usually improve when supplements stop, but ask your doctor before changing anything.
No refund or settlement has been announced. Check the return policy of the store where you bought it, and keep your receipt.
You do not need to join a proposed class action. If a class is certified or a settlement is reached, you will get a notice that explains your options. You can also talk to a lawyer about your own claim.
The complaint says Nestlé Health Science acquired Solgar in 2021, and Nestlé S.A. is also named as a defendant.